[1]
2024. Genetic Polymorphism in CYP3A4 and CYP3A5 Genes and their Association with the Clinical Response to Calcineurin Inhibitors; A Narrative Review. Precision Medicine Communications. 4, 01 (Jun. 2024), 21–40. DOI:https://doi.org/10.55627/pmc.004.001.0554.